FILTER
FILTERED INTERVIEW RESULTS
Hui Hui Kiw
VP ASIA, MACDERMID ENTHONE INDUSTRIAL SOLUTIONS
"Companies across China are transferring segments of their business to Thailand, a top choice among Chinese automakers and component manufacturers, with Vietnam, the Philippines, and Indonesia gaining new investments as well."
Daniel Prince
CEO, PRINCE STERILIZATION SERVICES
"We are extremely excited about the growth our hydrogen peroxide and packaging segments can bring."
Rajendra Shah & Janki Shah
DIRECTOR (RS) AND DIRECTOR (JS), MERCURY LABORATORIES
"After the pandemic, India has become one of the most recognized medical suppliers to the world as the country has shown that it can supply to ever increasing demands."
Ajay Tandon
MANAGING DIRECTOR, VEEDA CLINICAL RESEARCH
"We now offer end-to-end modular technical services, encompassing both pre-clinical and clinical development of biosimilars addressing global regulatory requirements."
Gaurav Kaushik
MANAGING DIRECTOR AND CEO, METEORIC BIOPHARMACEUTICALS
"We are looking into new ways to reap the benefits of artificial intelligence, particularly on the clinical side. On the physical side, Meteoric Biopharmaceuticals will have a new factory and lab up and running by the end of 2024, that will work on advanced fermentation processes."
Anwar Daud
MANAGING DIRECTOR, ZIM LABORATORIES
"ZIM sees great opportunity in improving the functioning of the overall healthcare system through providing more patient centric drug delivery systems."
Krishna Kanumuri
CEO & MANAGING DIRECTOR, SAI LIFE SCIENCES
"The biotech industry in India is currently extremely nascent, but it is evolving fast as generic margins drop, and many companies are starting to explore more innovative approaches to doing business. I anticipate Sai will take on more companies in the biotech sector in the future."
Bindi Chudgar
MANAGING DIRECTOR, LAMBDA THERAPEUTIC RESEARCH
"With our expanding global footprint, we firmly believe that we are well positioned to achieve the vision of creating benchmarks and shaping the future of the clinical research industry by ensuring quality, reliability, and value-added services.”
Karan Singh
MANAGING DIRECTOR, ACG
"Personalized medicine will disrupt the pharma industry. I also see more people looking to leverage the digitization of patient care, such as through telemedicine or the creation of wearable technologies."
Dr. Hemant Koshia
COMMISSIONER, FDCA (FOOD AND DRUG CONTROL ADMINISTRATION) GUJARAT
"In addition to pharmacy graduates, the pharmaceutical industry requires support from other industries like chemicals and petrochemicals, as well as top quality pharmacy machinery manufacturers. In Gujarat, we have all of this."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
